When Did The Women's Health Initiative Study End?
In 2002, the estrogen plus progestin (E+P) trial of the WHI was terminated after 5.6 years, having found no coronary benefit and a rate of breast cancer that crossed preset boundaries (6).
What is the women's health Initiative study?
The Women's Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), is a long-term national health study that focuses on strategies for preventing heart disease, breast and colorectal cancer, and osteoporosis in postmenopausal women.
Women's Health Initiative (WHI) | NHLBI, NIH
Women's Health Initiative (WHI)
Women's Health Initiative (WHI) - Full Text View - ClinicalTrials ...
Why was the WHI study terminated early?
One treatment-arm of the Women's Health Initiative (WHI) study was recently terminated because the overall risks of hormone treatment were considered to outweigh the benefits. The main findings were an increased risk of venous thromboembolism and a decreased risk of osteoporotic fractures with treatment.
[After the early termination of the Women's Health Initiative study ...
Chicago, IL - A trial comparing estrogen plus progestin with placebo as a primary prevention strategy for healthy postmenopausal womenpart of the Women's Health Initiative (WHI)has been stopped because of apparent increased risks of invasive breast cancer, coronary heart disease events, stroke, and pulmonary embolism ...
HRT arm of WHI stopped - Medscape